Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesStocksEarnInstitutionAI & More
Crypto Faces 'Very Bad News' as CLARITY Act Vote Risks Delay

Crypto Faces 'Very Bad News' as CLARITY Act Vote Risks Delay

UTodayUToday2026/09/04 07:42

The House will now return to Washington on Sept. 14 for what is expected to be a four-day session before leaving the capital until after the midterm elections, according to Roll Call. 

The timing could create a major obstacle for the market structure bill. The Senate is scheduled to return from its August recess on Sept. 14 and is expected to hold an initial vote on the CLARITY Act on Sept. 15. However, even if the legislation clears the Senate, the House would still need to pass the Senate-approved version before it gets signed into law. 

He claims that the shortened House schedule could push a CLARITY Act vote into the post-election “lame duck” period, when the makeup of Congress could be set to change.

Alex Thorn, head of firmwide research at Galaxy Digital, likewise said the shortened September session makes it "extremely unlikely" that CLARITY will pass before the midterm elections.

The Senate has roughly three weeks of legislative session between Sept. 15 and the first week of October, but the House’s shortened schedule leaves little time for the chambers to act in sequence.

The House’s decision comes as lawmakers face increasing pressure to return home and campaign ahead of the midterm elections. Roll Call reported that Speaker Mike Johnson and Republican lawmakers scrapped the final two weeks of September, with the chamber now expected to remain out through the election.

A delay until after the midterms could introduce fresh uncertainty over the bill’s prospects (considering that the Democrats are likely to win the House). 

Stumbling in the Senate 

The House passed its version of the CLARITY Act in July 2025 by 294-134, giving the legislation a remarkably large bipartisan margin. The problem is that the Senate did not simply take up the House bill.

Senate Banking and Senate Agriculture have worked on their own approaches and amendments, and the bill needs votes from a total of 60 senators. 

The two chambers will still have to resolve differences before the bill becomes law. 

0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

Just about three months after listing, two SK Hynix leveraged ETFs are set to be delisted in the United States.

Tradr ETFs announced that its two leveraged products linked to SK Hynix ADRs will be liquidated and delisted around November 12, with one being long and the other short. Despite only being listed for a few months, their combined scale has shrunk to about $1.3 million, down more than 60% from their peak. SK Hynix's Seoul stock price has fallen 56% from its high, similar products in the industry are generally under pressure, and South Korea has also further tightened regulations on leveraged products.

华尔街见闻•2026/10/26 05:56
Just about three months after listing, two SK Hynix leveraged ETFs are set to be delisted in the United States.

A $5 billion single-product emerges? JPMorgan maintains a "Neutral" rating on Amgen (AMGN.US): A good drug doesn't necessarily mean a good buying opportunity.

Amgen's Imdelltra has maintained data with an HR of 0.42, nearly doubling survival time. Morgan Stanley estimates that it will become a single product with annual sales of around 5 billions USD. However, they maintain a Neutral rating and a target price of 350 USD.

智通财经•2026/10/26 04:20
A $5 billion single-product emerges? JPMorgan maintains a "Neutral" rating on Amgen (AMGN.US): A good drug doesn't necessarily mean a good buying opportunity.